Skip to main content

ChEMBL 28 Released!

By

 We are pleased to announce the release of ChEMBL_28. This version of the database, prepared on 15/01/2021 contains:

* 2,680,904 compound records
* 2,086,898 compounds (of which 2,066,376 have mol files)
* 17,276,334 activities
* 1,358,549 assays
* 14,347 targets
* 80,480 documents

Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_28.

Please see ChEMBL_26 release notes for full details of all changes in this release: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_28/chembl_28_release_notes.txt

DATA CHANGES SINCE THE LAST RELEASE

This release includes several new deposited data sets:

Donated Chemical Probes data from SGC Frankfurt (src_id = 54)
SARS-CoV-2 screening data from the Fraunhofer Institute (src_id = 52)
Antimicrobial screening data sets from CO-ADD (src_id = 40)
Plasmodium screening data from the UCSD Winzeler lab (src_id = 51)
MMV pathogen box screening data (src_id = 34)

Curated data sets:

Drug safety warning information:
Safety-related information for approved drugs has been curated to include the assignment of toxicity classes (e.g., Cardiotoxicity, Hepatotoxicity Teratogenicity etc), based on their withdrawn status and/or black box warning information described on medicinal product labels. Two new tables have been included in ChEMBL to hold this information: DRUG_WARNING and WARNING_REFS and a new web service endpoint is also available: https://www.ebi.ac.uk/chembl/api/data/drug_warning. For more information about this data set and the methods used, please see: https://doi.org/10.1021/acs.chemrestox.0c00296
This information can be seen on the Compound Report Card for the relevant drugs e.g., https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL118/


Metabolism Pathways:
Further metabolic pathways have been curated from the Journal of Drug Metabolism and Disposition and are included in the METABOLISM table. This dataset comprises more than 900 additional reactions in pathways for 98 distinct drugs/compounds. Where available, this information is displayed on the Compound Report Card e.g., https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1370/



Prodrug active ingredients (src_id = 53):
Compound records have now been included for active ingredients that are formed through metabolic activation of prodrugs. These active ingredients have also been updated in the molecule_hierarchy (as the ACTIVE_MOLREGNO) to link them to the corresponding prodrug (PARENT_MOLREGNO).

The following data sources have also been updated:

Scientific Literature, Patent Bioactivity Data, USP Dictionary of USAN and International Drug Names, Clinical Candidates, WHO Anatomical Therapeutic Chemical Classification, Orange Book, Manually Added Drugs

OTHER CHANGES TO THE WEB INTERFACE:

  • Advanced search with a list of molecule or target ChEMBL IDs is now available (see separate blog post for more details):
  • Assay parameters and activity properties included on Browse Activities view (these columns are hidden initially and need to be added with the 'Show/hide columns' button). Since there can be multiple parameters/properties for an assay/activity, these columns show a concatenated list.
  • Variant sequences information included on Assay Report Card and Browse Activities view e.g., https://www.ebi.ac.uk/chembl/assay_report_card/CHEMBL1937980/
  • Obsolete or downgraded ChEMBL IDs now resolve to a message page that indicates the status of each entity. For example, https://www.ebi.ac.uk/chembl/id_lookup/CHEMBL101033  indicates that the compound has been permanently removed from the database and https://www.ebi.ac.uk/chembl/id_lookup/CHEMBL102436 indicates that the compound is currently downgraded in ChEMBL_28. If a user is not sure what type of entity a given ChEMBL ID corresponds to, they can now use a single URL with any type of ChEMBL ID (compound/target/assay/document/cell/tissue) and it will resolve to the correct Report Card page e.g., https://www.ebi.ac.uk/chembl/entity/CHEMBL25 or https://www.ebi.ac.uk/chembl/entity/CHEMBL2971. Furthermore, if the wrong report card URL is used for a valid ChEMBL ID, it will be redirected to the correct Report Card page (e.g., https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL25/ will redirect to https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL25/, since CHEMBL25 is a compound).

DATABASE CHANGES SINCE THE LAST RELEASE

Columns Added:

DRUG_MECHANISM
COLUMN_NAME DATA_TYPE COMMENT
VARIANT_ID NUMBER(9,0) Foreign key to VARIANT_SEQUENCES table, indicating that the drug targets a specific variant form of the protein.

Columns Removed:

MOLECULE_DICTIONARY
The following columns are deprecated (replaced by the new tables below) and will be removed in a future release:
WITHDRAWN_YEAR
WITHDRAWN_COUNTRY
WITHDRAWN_REASON
WITHDRAWN_CLASS

Tables Added:

DRUG_WARNING
COLUMN_NAME DATA_TYPE COMMENT
WARNING_ID NUMBER(9,0 Primary key for the drug warning
RECORD_ID NUMBER(9,0) Foreign key to the compound_records table
MOLREGNO NUMBER(9,0) Foreign key to molecule_dictionary table
WARNING_TYPE VARCHAR2(20 BYTE) Description of the drug warning type (e.g., withdrawn vs black box warning)
WARNING_CLASS VARCHAR2(100 BYTE) High-level class of the drug warning
WARNING_DESCRIPTION VARCHAR2(4000 BYTE) Description of the drug warning
WARNING_COUNTRY VARCHAR2(1000 BYTE) List of countries/regions associated with the drug warning
WARNING_YEAR NUMBER(4,0) Year the drug was first shown the warning

WARNING_REFS
COLUMN_NAME DATA_TYPE COMMENT
WARNREF_ID NUMBER(9,0) Primary key for the warning reference
WARNING_ID NUMBER(9,0) Foreign key to the drug_warning table
REF_TYPE VARCHAR2(50 BYTE) Type/source of reference
REF_ID VARCHAR2(4000 BYTE) Identifier for the reference in the source
REF_URL VARCHAR2(4000 BYTE) Full URL linking to the reference

CHANGES TO WEB SERVICES AND DOWNLOADS

The following changes have been made to web services:
Assay, Activity and Mechanism endpoints now include variant sequence information

Download formats:
Please note, from ChEMBL_29 onward, we will no longer be able to provide Oracle 10g/11g/12c dumps. Only Oracle 19c dumps will be provided (in addition to the usual PostgreSQL/MySQL/SQLite dumps).

Funding acknowledgements:

Work contributing to ChEMBL28 was funded by the Wellcome Trust, EMBL Member States, Open Targets, National Institutes of Health (NIH), EU Innovative Medicines Initiative 2 (IMI2) and EU Horizon 2020 programmes. Please see https://chembl.gitbook.io/chembl-interface-documentation/acknowledgments for more details.

If you require further information about ChEMBL, please contact us: chembl-help@ebi.ac.uk

# To receive updates when new versions of ChEMBL are available, please sign up to our mailing list: http://listserver.ebi.ac.uk/mailman/listinfo/chembl-announce
# For general queries/feedback or to report any problems with data, please email: chembl-help@ebi.ac.uk
# For details of upcoming webinars, please see: http://chembl.blogspot.com/search/label/Webinar

Comments

Post a Comment

Popular posts from this blog

New SureChEMBL announcement

By
(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f
Post a Comment
Read more

Improved querying for SureChEMBL

By
    Dear SureChEMBL users, Earlier this year we ran a survey to identify what you, the users, would like to see next in SureChEMBL. Thank you for offering your feedback! This gave us the opportunity to have some interesting discussions both internally and externally. While we can't publicly reveal precisely our plans for the coming months (everything will be delivered at the right time), we can at least say that improving the compound structure extraction quality is a priority. Unfortunately, the change won't happen overnight as reprocessing 167 millions patents takes a while. However, the good news is that the new generation of optical chemical structure recognition shows good performance, even for patent images! We hope we can share our results with you soon. So in the meantime, what are we doing? You may have noticed a few changes on the SureChEMBL main page. No more "Beta" flag since we consider the system to be stable enough (it does not mean that you will never
Post a Comment
Read more

ChEMBL brings drug bioactivity data to the Protein Data Bank in Europe

By
In the quest to develop new drugs, understanding the 3D structure of molecules is crucial. Resources like the Protein Data Bank in Europe (PDBe) and the Cambridge Structural Database (CSD) provide these 3D blueprints for many biological molecules. However, researchers also need to know how these molecules interact with their biological target – their bioactivity. ChEMBL is a treasure trove of bioactivity data for countless drug-like molecules. It tells us how strongly a molecule binds to a target, how it affects a biological process, and even how it might be metabolized. But here's the catch: while ChEMBL provides extensive information on a molecule's activity and cross references to other data sources, it doesn't always tell us if a 3D structure is available for a specific drug-target complex. This can be a roadblock for researchers who need that structural information to design effective drugs. Therefore, connecting ChEMBL data with resources like PDBe and CSD is essen
Post a Comment
Read more

ChEMBL & SureChEMBL anniversary symposium

By
  In 2024 we celebrate the 15th anniversary of the first public release of the ChEMBL database as well as the 10th anniversary of SureChEMBL. To recognise this important landmark we are organising a two-day symposium to celebrate the work achieved by ChEMBL and SureChEMBL, and look forward to its future.   Save the date for the ChEMBL 15 Year Symposium October 1-2, 2024     Day one will consist of four workshops, a basic ChEMBL drug design workshop; an advanced ChEMBL workshop (EUbOPEN community workshop); a ChEMBL data deposition workshop; and a SureChEMBL workshop. Day two will consist of a series of talks from invited speakers, a few poster flash talks, a local nature walk, as well as celebratory cake. During the breaks, the poster session will be a great opportunity to catch up with other users and collaborators of the ChEMBL resources and chat to colleagues, co-workers and others to find out more about how the database is being used. Lunch and refreshments will be pro
Post a Comment
Read more

ChEMBL 34 is out!

By
We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.
Post a Comment
Read more